Homepage Top Section1

The company, through its new drug application (NDA), has been seeking FDA approval for selpercatinib for the treatment of advanced RET fusion-positive non-small cell lung cancer (NSCLC), RET

In this connection, Accenture will use Google Cloud as the cloud technology provider for its INTIENT life sciences industry platform. The new, multi-year partnership will see Google’s cloud

The deals are being carried out to help in facilitating the closing of the previously announced $63bn acquisition of Allergan by AbbVie. Brazikumab is an investigational IL-23 inhibitor,

DS-8201 is trastuzumab deruxtecan in Japan and other regions of world barring the US where it is fam-trastuzumab deruxtecan-nxki. The mid-stage trial for the ADC was held in

North Carolina Governor Roy Cooper has also announced that Eli Lilly’s move will also help to create over 460 new jobs in the Durham region. The new job

The approval for Mayzent from the European Commission (EC) is for SPMS with active disease, confirmed by relapses or imaging features of inflammatory activity. The sphingosine 1-phosphate receptor

The Japan Ministry of Health, Labour and Welfare (MHLW) has approved Dovato to treat HIV-1 infection in adults and adolescents above12 years of age with a minimum of

Under the marketing authorisation application (MAA) submitted to the European Medicines Agency (EMA), the company has asked the regulator to review the potential use of fostemsavir in combination

Keytruda has been approved to treat patients with BCG- unresponsive, high-risk NMIBC with carcinoma in situ (CIS) with or without papillary tumours who are ineligible for or have